Purchase Order 75N95024P00082
Award Date
1/12/24
Potential Completion Date
1/11/29
Potential Value
$173K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Quanterix Corporation
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $180,806 firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company that provides digital biomarker detection technology. The contract is for a SIMOA HD-X analyzer, which will replace the Institute's aging HD-1 platform and be used by the entire NIA Intramural Research Program. Quanterix has received over $30 million in prior federal contracts from...
The National Institute on Aging (NIA), an agency within the National Institutes of Health (NIH), awarded a firm fixed-price purchase order to Quanterix Corporation for annual maintenance support services and a warranty package for a Simoa HD-1 Analyzer. The purchase order, valued at $26,600.00, has a period of performance from May 7, 2021 to May 6, 2022. The Simoa HD-1 Analyzer is used by NIA for the Freezer Farm Quality Control project, which tests control pools of human serum and plasma to...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
This firm-fixed-price purchase order was awarded by the National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $3,070.94 contract is for the procurement of Quanterix's Simoa (single molecule array) biomarker detection equipment and related maintenance services. Quanterix has received multiple federal contract awards...
Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...
This is a firm fixed-price service contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Quanterix Corporation, a for-profit manufacturer of digital biomarker analysis technology. The contract, valued at $15,000.00, is for Quanterix to provide Simoa detection platform instruments, assay kits, reagents, and maintenance services to support NIH research on diseases such as Alzheimer's, post-traumatic stress disorder, and infectious...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...